Joslin Diabetes Center Research | Research Updates from Joslin Diabetes Center
Established in 1898, Joslin Diabetes Center is an internationally recognized diabetes treatment, research and education institution affiliated with Harvard Medical School and headquartered in Boston, MA. Joslin is a non-profit organization dedicated to finding a cure for diabetes and improving the lives of people with diabetes through its cutting edge basic and clinical research, patient care programs for children and adults, and through programs and publications that improve the care of diabetes worldwide. Some of the most important improvements in diabetes care — including treatments for diabetes in pregnancy, the development of laser surgery to treat diabetic eye disease, and the identification of markers for "pre-diabetes" — were developed at Joslin. In addition to its headquarters facility in Boston, Joslin has affiliated treatment facilities at more than 25 locations from coast to coast. Support Joslin research now.
Recent Research From Joslin
Beta Cells Need Key Protein to Divide and Conquer Diabetes
Joslin Diabetes Center and dLife Form Online Partnership
Relieving Stress on Beta Cells May Aid in Diabetes
Joslin Finds New Drug Targets for Diabetes Eye Complications
Joslin Study Identifies Gene Linked to Rare Form of Diabetes
Joslin Diabetes Center President and CEO Ranch C. Kimball to Step Down
Joslin Study Identifies ‘Good’ Energy Burning Fat in Lean Adults
Richard R. Crater Joins Joslin Diabetes Center as Chief Financial Officer
Joslin Receives $1 Million to Support Type 1 Diabetes Research
Joslin Identifies Source of Beta Cell Damage
High Blood Glucose Levels in Early Pregnancy May Deprive Embryo of Oxygen and Lead to Birth Defects, Joslin Diabetes Center Study Shows
New Imaging Technology Shown to Detect Pancreatic Inflammation in Type 1 Diabetes and Its Reversal in Animal Models
Joslin Researchers Discover New Gene for Type 2 Diabetes Using DNA Chip
Diabetes - Is it in Your Genes?
Eyes on the Prize: Preventing Vision Problems Associated With Diabetes
Not Quite An Artificial Pancreas: Insulin Pumps and Glucose Sensor Devices
Obesity: It's Gaining On Us
As I mentioned in an earlier post, one of the benefits that made it cost-effective for me to go with the real healthcare (HSA) plan rather than the phony (HRA) plan is that my company is now covering "preventative" medicines at $0 copay. The formulary for these, as stated by CVS/Caremark (my pharmacy benefits provider), covers all test strips, lancets, and control solutions. I dutifully get my doctor to write up prescriptions for all of my testing needs, submit...